Literature DB >> 8532262

Transvaginal mobilization and removal of ovaries and fallopian tubes after vaginal hysterectomy.

L A Ballard1, M D Walters.   

Abstract

OBJECTIVE: To describe a technique of transvaginal mobilization and removal of ovaries and tubes, and to assess its use in older women undergoing vaginal hysterectomy.
METHODS: Charts of 151 women age 50 and older who underwent vaginal hysterectomy by one senior gynecologic surgeon during 1991-1993 were reviewed.
RESULTS: Ninety of 138 women (65%) who chose ovarian removal had their ovaries successfully removed vaginally. In 48 women, one or both ovaries were examined and noted to be normal, and they were not removed or could not be removed vaginally. Operating time, estimated blood loss, length of hospital stay, and rates of intraoperative complications and postoperative morbidity did not differ significantly in the bilateral salpingo-oophorectomy and ovarian conservation groups.
CONCLUSION: Transvaginal removal of ovaries and tubes can be achieved in about two-thirds of women undergoing vaginal hysterectomy with minimal or no increases in operating time and surgical morbidity.

Entities:  

Mesh:

Year:  1996        PMID: 8532262     DOI: 10.1016/0029-7844(95)00346-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Hysterectomy for heavy menstrual bleeding.

Authors:  Eva van der Meij; Mark Hans Emanuel
Journal:  Womens Health (Lond)       Date:  2016-01-12

2.  Feasibility of prophylactic salpingectomy during vaginal hysterectomy.

Authors:  Danielle D Antosh; Rachel High; Heidi W Brown; Sallie S Oliphant; Husam Abed; Nisha Philip; Cara L Grimes
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 8.661

3.  Adnexal surgery at the time of hysterectomy in women 65 years and older undergoing hysterectomy for prolapse: do practice trends differ by route of surgery?

Authors:  Kristie A Greene; Allison M Wyman; Nupur Tamhane; Jean Paul Tanner; Renee M Bassaly; Jason L Salemi
Journal:  Int Urogynecol J       Date:  2021-03-03       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.